Inventor · disambiguated record
James F Winchester
Also filed as: WINCHESTER JAMES F
7 granted patents·11 pending applications·90 citations·filing 2001–2010
86Inventor score
Files withRENAL TECH INTERNAT5RENALTECH INTERNATIONAL LLC4BRADY JAMES A2CYTOSORBENTS INC2RENAL TECH INTERNAT LLC2
Top patents by PatentIndex Score
18 records- 0193US8349550B2Methods for reducing levels of pro-inflammatory or anti-inflammatory stimulators or mediators in the bloodCYTOSORBENTS INC·Filed 2010·Granted Jan 8, 2013·16 cites·3 claims
- 0289US7846650B2Methods for reducing levels of pro-inflammatory or anti-inflammatory stimulators or mediators in the bloodCYTOSORBENTS INC·Filed 2007·Granted Dec 7, 2010·11 cites·15 claims
- 0389US7556768B2Biocompatible devices, systems, and methods for reducing levels of pro-inflammatory or anti-inflammatory stimulators or mediators in the bloodMEDASORB CORP·Filed 2007·Granted Jul 7, 2009·18 cites·3 claims
- 0485US8334094B2Devices, systems, and methods for reducing levels of pro-inflammatory or anti-inflammatory stimulators or mediators in blood productsBRADY JAMES A·Filed 2010·Granted Dec 18, 2012·3 cites·6 claims
- 0585US8329388B2Biocompatible devices, systems, and methods for reducing levels of proinflammatory of antiinflammatory stimulators or mediators in the bloodBRADY JAMES A·Filed 2010·Granted Dec 11, 2012·5 cites·3 claims
- 0681US7312023B2Devices, systems, and methods for reducing levels of pro-inflammatory or anti-inflammatory stimulators or mediators in the blood, generated as a result of extracorporeal blood processingRENALTECH INTERNATIONAL LLC·Filed 2004·Granted Dec 25, 2007·18 cites·7 claims
- 0778US6878127B2Devices, systems, and methods for reducing levels of pro-inflammatory or anti-inflammatory stimulators or mediators in the bloodRENALTECH INTERNATIONAL LLC·Filed 2001·Granted Apr 12, 2005·19 cites·24 claims
- 0865US2010069816A1Biocompatible devices, systems, and methods for reducing levels of proinflammatory or antiinflammatory stimulators or mediators in the bloodRENALTECH INTERNATIONAL LLC·Filed 2009·Application pending·0 cites
- 0959US2005239041A1Devices, systems, and methods for reducing levels of pro-inflammatory or anti-inflammatory stimulators or mediators in blood productsRENALTECH INTERNAT·Filed 2005·Application pending·0 cites
- 1052US2007093739A1Selective adsorption devices and systemsRENAL TECH INTERNAT LLC·Filed 2006·Application pending·0 cites
- 1151US2002197249A1Devices, systems, and methods for reducing levels of pro-inflammatory or anti-inflammatory stimulators or mediators in blood productsRENAL TECH INTERNAT·Filed 2001·Application pending·0 cites
- 1249US2011210074A1Removal of myoglobin from blood and/or physiological fluidsWINCHESTER JAMES F·Filed 2009·Application pending·0 cites
- 1348US2005061742A1Devices, systems, and methods for reducing levels of pro-inflammatory or anti-inflammatory stimulators or mediators in physiologic fluidsRENAL TECH INTERNAT LLC·Filed 2004·Application pending·0 cites
- 1448US2006057142A1Biocompatible devices, systems, and methods for reducing levels of pro-inflammatory or anti-inflammatory stimulators or mediators in the bloodRENALTECH INTERNATIONAL LLC·Filed 2005·Application pending·0 cites
- 1545US2002159995A1Devices, systems, and methods for reducing levels of pro-inflammatory or anti-inflammatory stimulators or mediators in the blood, generated as a result of extracorporeal blood processingRENAL TECH INTERNAT·Filed 2001·Application pending·0 cites
- 1643US2002198487A1Devices, systems, and methods for reducing levels of pro-inflammatory or anti-inflammatory stimulators or mediators in physiologic fluidsRENAL TECH INTERNAT·Filed 2001·Application pending·0 cites
- 1743US2002197252A1Selective adsorption devices and systemsRENAL TECH INTERNAT·Filed 2001·Application pending·0 cites
- 1842US2002197250A1Biocompatible devices, systems, and methods for reducing levels of pro-inflammatory or anti-inflammatory stimulators or mediators in the bloodRENAL TECH INTERNAT·Filed 2001·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →